Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRISTARDS trial
NL-OMON52082Phase 2Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tissue-plasminogen activator in acute respiratory distress syndrome (ARDS) and coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Boehringer Ingelheim. Started Mar 2021; status: active, not recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
acute respiratory distress syndrome (ARDS)coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON52082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52082.